Showing results (1691-1700 of 2,623) with videos related to

Sort By:
Pageof 263
American Journal of Otolaryngology|February 6, 2019
Reliability of clinical diagnosis of masses of the cerebellopontine angle: A retrospective multi-institutional studyAlexander L Luryi, Elias M Michaelides, Seilesh Babu, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Clinical staging in pancreatic adenocarcinoma underestimates extent of diseaseAkhil Chawla, Jennifer Wo, Carlos Fernandez-Del Castillo, et al.
Investigational New Drugs|December 6, 2016
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumorsMuhammad S Beg, Andrew J Brenner, Jasgit Sachdev, et al.
Journal of Psychiatric Research|November 9, 2018
Neuroanatomical abnormalities in fragile X syndrome during the adolescent and young adult yearsGisela M Sandoval, Sehoon Shim, David S Hong, et al.
British Journal of Cancer|June 27, 2014
Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancerE Jwa, J H Kim, S Han, et al.
Communications Biology|November 10, 2023
Repeated multi-domain cognitive training prevents cognitive decline, anxiety and amyloid pathology found in a mouse model of Alzheimer diseaseJogender Mehla, Scott H Deibel, Hadil Karem, et al.
IEEE Transactions on Bio-Medical Engineering|April 23, 2026
Deep Brain Stimulation: Past, Present, and FutureMinhye Choo, Yoonbae Oh, Lydia S Hong, et al.
Breast Cancer Research and Treatment|January 5, 2019
A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer typesPatrick H Dinkelborg, Meng Wang, Liliana Gheorghiu, et al.
Investigational New Drugs|November 22, 2013
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumorsD S Hong, R Kurzrock, A Naing, et al.
Frontiers in Immunology|November 28, 2022
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical dataJi Son, Rodney Cheng-En Hsieh, Heather Y Lin, et al.
Pageof 263